Orthofix Medical Inc.
OFIX
$16.09
-$0.05-0.31%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 205.63M | 203.12M | 193.65M | 215.66M | 196.61M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 205.63M | 203.12M | 193.65M | 215.66M | 196.61M |
| Cost of Revenue | 57.11M | 63.59M | 72.03M | 63.77M | 61.55M |
| Gross Profit | 148.52M | 139.53M | 121.62M | 151.89M | 135.05M |
| SG&A Expenses | 147.80M | 136.49M | 132.98M | 136.48M | 129.84M |
| Depreciation & Amortization | 3.12M | 3.87M | 3.04M | 4.34M | 4.55M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 222.81M | 219.89M | 227.81M | 223.40M | 213.24M |
| Operating Income | -17.17M | -16.77M | -34.17M | -7.74M | -16.63M |
| Income Before Tax | -22.26M | -14.22M | -52.13M | -29.71M | -26.64M |
| Income Tax Expenses | 533.00K | -142.00K | 961.00K | -564.00K | 751.00K |
| Earnings from Continuing Operations | -22.80M | -14.08M | -53.09M | -29.15M | -27.39M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -22.80M | -14.08M | -53.09M | -29.15M | -27.39M |
| EBIT | -17.17M | -16.77M | -34.17M | -7.74M | -16.63M |
| EBITDA | -2.65M | 1.23M | 1.52M | 19.55M | 159.00K |
| EPS Basic | -0.57 | -0.36 | -1.35 | -0.75 | -0.71 |
| Normalized Basic EPS | -0.35 | -0.24 | -0.60 | -0.41 | -0.40 |
| EPS Diluted | -0.57 | -0.36 | -1.35 | -0.75 | -0.71 |
| Normalized Diluted EPS | -0.35 | -0.24 | -0.60 | -0.41 | -0.40 |
| Average Basic Shares Outstanding | 39.77M | 39.50M | 39.19M | 38.70M | 38.49M |
| Average Diluted Shares Outstanding | 39.77M | 39.50M | 39.19M | 38.70M | 38.49M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |